GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cantel Medical Corp (NYSE:CMD) » Definitions » ROA %

Cantel Medical (Cantel Medical) ROA % : 4.14% (As of Apr. 2021)


View and export this data going back to 1992. Start your Free Trial

What is Cantel Medical ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Cantel Medical's annualized Net Income for the quarter that ended in Apr. 2021 was $84 Mil. Cantel Medical's average Total Assets over the quarter that ended in Apr. 2021 was $2,041 Mil. Therefore, Cantel Medical's annualized ROA % for the quarter that ended in Apr. 2021 was 4.14%.

The historical rank and industry rank for Cantel Medical's ROA % or its related term are showing as below:

CMD' s ROA % Range Over the Past 10 Years
Min: 0.87   Med: 8.57   Max: 10.34
Current: 2.51

During the past 13 years, Cantel Medical's highest ROA % was 10.34%. The lowest was 0.87%. And the median was 8.57%.

CMD's ROA % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -2.01 vs CMD: 2.51

Cantel Medical ROA % Historical Data

The historical data trend for Cantel Medical's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantel Medical ROA % Chart

Cantel Medical Annual Data
Trend Jul11 Jul12 Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.38 9.64 10.40 5.41 0.87

Cantel Medical Quarterly Data
Jul16 Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.32 -1.12 4.76 2.36 4.14

Competitive Comparison of Cantel Medical's ROA %

For the Medical Instruments & Supplies subindustry, Cantel Medical's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cantel Medical's ROA % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cantel Medical's ROA % distribution charts can be found below:

* The bar in red indicates where Cantel Medical's ROA % falls into.



Cantel Medical ROA % Calculation

Cantel Medical's annualized ROA % for the fiscal year that ended in Jul. 2020 is calculated as:

ROA %=Net Income (A: Jul. 2020 )/( (Total Assets (A: Jul. 2019 )+Total Assets (A: Jul. 2020 ))/ count )
=13.708/( (1070.366+2071.754)/ 2 )
=13.708/1571.06
=0.87 %

Cantel Medical's annualized ROA % for the quarter that ended in Apr. 2021 is calculated as:

ROA %=Net Income (Q: Apr. 2021 )/( (Total Assets (Q: Jan. 2021 )+Total Assets (Q: Apr. 2021 ))/ count )
=84.472/( (2050.31+2031.278)/ 2 )
=84.472/2040.794
=4.14 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Apr. 2021) net income data. ROA % is displayed in the 30-year financial page.


Cantel Medical  (NYSE:CMD) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Apr. 2021 )
=Net Income/Total Assets
=84.472/2040.794
=(Net Income / Revenue)*(Revenue / Total Assets)
=(84.472 / 1255.812)*(1255.812 / 2040.794)
=Net Margin %*Asset Turnover
=6.73 %*0.6154
=4.14 %

Note: The Net Income data used here is four times the quarterly (Apr. 2021) net income data. The Revenue data used here is four times the quarterly (Apr. 2021) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Cantel Medical ROA % Related Terms

Thank you for viewing the detailed overview of Cantel Medical's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cantel Medical (Cantel Medical) Business Description

Traded in Other Exchanges
N/A
Address
150 Clove Road, 9th Floor, Little Falls, NJ, USA, 07424
Cantel Medical is a New Jersey-based manufacturer of hospital supplies for infection prevention, which include products used in endoscope disinfection, water purification systems for use in dialysis treatment, and dental supplies. The firm reports in four segments: medical (46% of fiscal 2020 sales), dental (32%), life sciences (19%), and dialysis (3%). Geographic exposure is primarily in the U.S., which accounts for about 75% of revenue, with international markets making up the remaining 25%.
Executives
Ann E Berman director 255 STATE STREET, BOSTON MA 02109
Jeffrey Z Mann officer: SVP, General Counsel 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
George L Fotiades director, officer: Chief Executive Officer 281 SUMMIT AVENUE, SUMMIT NJ 07901
Charles M Diker director, 10 percent owner, officer: Chairman ONE NEW YORK PLAZA, NEW YORK NY 10004
Shaun M. Blakeman officer: SVP - CFO C/O CANTEL MEDICAL CORP., 150 CLOVE ROAD, LITTLE FALLS NJ 07424
Jean Casner officer: SVP and CHRO 150 CLOVE ROAD, LITTLE FALLS NJ 07424
Brian Capone officer: SVP and Princ. Accounting Ofr 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
Peter G Clifford officer: President and COO 40 TOURNAMENT DRIVE SOUTH, HAWTHORN WOODS IL 60047
Seth M Yellin officer: Executive Vice President 150 CLOVE ROAD 9TH FLOOR LITTLE FALLS NJ 07424
Laura L Forese director 849 STONEWALL COURT FRANKLIN LAKES NJ 07417
Peter Pronovost director JHU-QSRG 1909 THAMES ST. - 2ND FLOOR BALTIMORE MD 21231
Anthony B Evnin director C/O VENROCK ASSOCIATES, 7 BRYANT PARK, 23RD FLOOR, NEW YORK NY 10018
Ronnie Myers director TOURO COLLEGE OF DENTAL MEDICINE 40 SUNSHINE COTTAGE ROAD VALHALLA NY 10595
Alan R Batkin director 399 PARK AVENUE, 10TH FLOOR, NEW YORK NY 10022
Karen Prange director 1108 S RIO VISTA BLVD, FORT LAUDERDALE FL 33316

Cantel Medical (Cantel Medical) Headlines